RS59499B1 - Proces za dobijanje optički aktivnih enantiomera pirlindola i njihovih soli - Google Patents

Proces za dobijanje optički aktivnih enantiomera pirlindola i njihovih soli

Info

Publication number
RS59499B1
RS59499B1 RS20191433A RSP20191433A RS59499B1 RS 59499 B1 RS59499 B1 RS 59499B1 RS 20191433 A RS20191433 A RS 20191433A RS P20191433 A RSP20191433 A RS P20191433A RS 59499 B1 RS59499 B1 RS 59499B1
Authority
RS
Serbia
Prior art keywords
salts
optically active
obtaining optically
pirlindole enantiomers
active pirlindole
Prior art date
Application number
RS20191433A
Other languages
English (en)
Inventor
Filipe Augusto Eugénio Pardal
Pedroso Pedro Filipe Eufrásio
Pecorelli Susana Marques Almeida
Caixado Carlos Alberto Eufrásio Casimiro
Ana Sofia Da Conceição Lopes
João Carlos Ramos Damil
Oliveira Santos Pedro Paulo De Lacerda E
Original Assignee
Tecnimede Sociedade Tecnico Medicinal S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tecnimede Sociedade Tecnico Medicinal S A filed Critical Tecnimede Sociedade Tecnico Medicinal S A
Publication of RS59499B1 publication Critical patent/RS59499B1/sr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06Peri-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B57/00Separation of optically-active compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
RS20191433A 2014-05-09 2014-05-09 Proces za dobijanje optički aktivnih enantiomera pirlindola i njihovih soli RS59499B1 (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/PT2014/000027 WO2015171003A1 (en) 2014-05-09 2014-05-09 Process for obtaining optically active pirlindole enantiomers and salts thereof
EP14726442.8A EP3140265B1 (en) 2014-05-09 2014-05-09 Process for obtaining optically active pirlindole enantiomers and salts thereof

Publications (1)

Publication Number Publication Date
RS59499B1 true RS59499B1 (sr) 2019-12-31

Family

ID=50819929

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20191433A RS59499B1 (sr) 2014-05-09 2014-05-09 Proces za dobijanje optički aktivnih enantiomera pirlindola i njihovih soli

Country Status (30)

Country Link
US (1) US9682986B2 (sr)
EP (1) EP3140265B1 (sr)
JP (1) JP6516769B2 (sr)
KR (1) KR102258709B1 (sr)
CN (1) CN106414376B (sr)
AU (1) AU2014393488C1 (sr)
BR (1) BR112016025918B1 (sr)
CA (1) CA2948604C (sr)
CY (1) CY1122367T1 (sr)
DK (1) DK3140265T3 (sr)
EC (1) ECSP16086217A (sr)
ES (1) ES2753403T3 (sr)
HR (1) HRP20192029T1 (sr)
HU (1) HUE046437T2 (sr)
IL (1) IL248853B (sr)
LT (1) LT3140265T (sr)
MA (1) MA39449A1 (sr)
MX (1) MX357918B (sr)
NZ (1) NZ726129A (sr)
PH (1) PH12016502234B1 (sr)
PL (1) PL3140265T3 (sr)
PT (1) PT3140265T (sr)
RS (1) RS59499B1 (sr)
RU (1) RU2666731C2 (sr)
SA (1) SA516380265B1 (sr)
SI (1) SI3140265T1 (sr)
TN (1) TN2016000496A1 (sr)
UA (1) UA118696C2 (sr)
WO (1) WO2015171003A1 (sr)
ZA (1) ZA201607722B (sr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015171003A1 (en) 2014-05-09 2015-11-12 Tecnimede Sociedade Tecnico-Medicinal S.A. Process for obtaining optically active pirlindole enantiomers and salts thereof
WO2015171002A1 (en) * 2014-05-09 2015-11-12 Tecnimede Sociedade Tecnico-Medicinal S.A. Pharmaceutically acceptable salts of pirlindole enantiomers for use in medicine
EP3392250A1 (en) * 2017-04-21 2018-10-24 Tecnimede-Sociedade Tecnico-Medicinal, S.A. Process for the preparation of piperazine ring for the synthesis of pyrazinocarbazole derivatives
EP3392251A1 (en) 2017-04-21 2018-10-24 Tecnimede-Sociedade Tecnico-Medicinal, S.A. Process for the preparation of pirlindole enantiomers and its salts

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2281085C2 (ru) * 2004-05-25 2006-08-10 Закрытое акционерное общество "Мастерлек" Антидепрессивные лекарственные средства для парентерального применения на основе сульфонатных солей пирлиндола
WO2015171003A1 (en) 2014-05-09 2015-11-12 Tecnimede Sociedade Tecnico-Medicinal S.A. Process for obtaining optically active pirlindole enantiomers and salts thereof

Also Published As

Publication number Publication date
UA118696C2 (uk) 2019-02-25
JP6516769B2 (ja) 2019-05-22
BR112016025918B1 (pt) 2023-05-16
NZ726129A (en) 2019-03-29
PH12016502234A1 (en) 2017-01-09
RU2666731C2 (ru) 2018-09-12
TN2016000496A1 (en) 2018-04-04
MA39449A1 (fr) 2017-11-30
EP3140265B1 (en) 2019-08-28
CN106414376B (zh) 2019-06-07
AU2014393488A1 (en) 2016-11-24
ES2753403T3 (es) 2020-04-08
SA516380265B1 (ar) 2019-11-04
MX2016014703A (es) 2017-05-23
US20170145024A1 (en) 2017-05-25
MX357918B (es) 2018-07-30
ZA201607722B (en) 2022-05-25
IL248853B (en) 2020-01-30
US9682986B2 (en) 2017-06-20
RU2016148181A (ru) 2018-06-13
CA2948604C (en) 2021-06-15
AU2014393488B2 (en) 2018-11-08
PT3140265T (pt) 2019-12-02
RU2016148181A3 (sr) 2018-06-13
KR102258709B1 (ko) 2021-06-01
PH12016502234B1 (en) 2017-01-09
ECSP16086217A (es) 2017-02-24
PL3140265T3 (pl) 2020-02-28
WO2015171003A1 (en) 2015-11-12
HRP20192029T1 (hr) 2020-02-07
SI3140265T1 (sl) 2019-12-31
EP3140265A1 (en) 2017-03-15
KR20170004995A (ko) 2017-01-11
IL248853A0 (en) 2017-01-31
LT3140265T (lt) 2019-12-10
HUE046437T2 (hu) 2020-03-30
CY1122367T1 (el) 2021-01-27
DK3140265T3 (da) 2019-11-18
CN106414376A (zh) 2017-02-15
BR112016025918A2 (sr) 2017-08-15
CA2948604A1 (en) 2015-11-12
JP2017514883A (ja) 2017-06-08
AU2014393488C1 (en) 2020-07-16

Similar Documents

Publication Publication Date Title
PL2957323T3 (pl) Głowica do zabiegów laserowych i układ lasera
IL279627A (en) A method for treating depression
GB201413335D0 (en) Agricultural methods
GB2542081B (en) Optical Member and Method for Producing Same
EP3110903A4 (en) Aqueous solution and methods for manufacture and use
EP3106465A4 (en) Method for preparing racemic or optically active glycerophosphoryl choline
PT2947728T (pt) Amplificador óptico, sistema de comunicação óptica wdm e método para amplificar opticamente um sinal óptico wdm
ZA201607722B (en) Process for obtaining optically active pirlindole enantiomers and salts thereof
IL248852B (en) Pharmaceutically acceptable salts of pyrilindole enantiomers for use in medicine
IL232649A0 (en) A method and system for cultivating grass
GB201406551D0 (en) A method and system for managing the health of a machine
IL246870B (en) Method for preparing 1-alkyl-3-difluoromethyl-5-fluoro-1h-pyrazole-4-carbaldehydes and 1-alkyl-3-difluoromethyl-5-fluoro-1h-pyrazole-4-carboxylates
GB2526063B (en) Optical amplifier
AU360448S (en) Cultivator
ZA201907515B (en) Process for the preparation of pirlindole enantiomers and its salts
GB201400927D0 (en) Ophthalmic apparatus
GB2522700B (en) Amplifier
TH1601006736A (th) กระบวนการสำหรับการได้รับมาของเพอร์ลินโดลอีแนนทิโอเมอร์ที่แอคทีฟเชิงออพติคอลและเกลือของสิ่งเหล่านี้
HUE056997T2 (hu) Eljárás pirlindol enantiomerek és sóik elkészítésére
PL3612535T3 (pl) Sposób otrzymywania enancjomerów pirlindolu i jego soli
EP3178815A4 (en) Method for producing optically active 2-methylpiperazine
GB201406790D0 (en) Laser treatment
GB201405427D0 (en) Disc Cultivator
SG11201606286XA (en) Fiber laser apparatus
AU2014905222A0 (en) Treatment of animal fibres